![]() |
0 new discussion posts (5 published)
Sign in to view your progression
|
ON-DEMAND
Identifying truly „actionable“ alterations: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
|
|
ON-DEMAND
PARP inhibition in ovarian cancer: Are we delivering precision medicine?
|
|
ON-DEMAND
Precision oncology in endometrial cancer: Might be the best example!
|
|
Q&A
Q&A - State of the art 2: Precision medicine in gynaecological oncology
|
|
{{ help_message }}
{{filter}}